In a two-center retrospective cohort study conducted in South Korea, researchers found that brain-dead donors supported by extracorporeal membrane oxygenation (ECMO) prior to organ procurement yielded abdominal organs with post-transplant recipient survival comparable to conventional donors, while thoracic organ recovery remained significantly lower. The study, published in the Journal of Intensive Care, analyzed 210 consecutive brain-dead organ donors managed at Samsung Medical Center and Pusan National University Yangsan Hospital between January 2012 and June 2025. The findings suggest that ECMO can preserve organ viability in a high-acuity population that would otherwise not survive to brain death determination, potentially expanding the donor pool in regions where donation after circulatory death is not legally permitted.
Organ shortages remain a critical global challenge, prompting the exploration of strategies to expand the donation after brain death (DBD) donor pool. ECMO, initially developed as a rescue therapy for severe cardiac or respiratory failure, has been applied in extracorporeal cardiopulmonary resuscitation (ECPR) for refractory cardiac arrest. In this context, ECMO maintains perfusion and gas exchange, mitigating ischemic injury and potentially preserving organ function. However, evidence regarding organ-specific recovery rates and post-transplant graft outcomes in ECMO-supported DBD donors has remained limited and heterogeneous, with particular uncertainty surrounding thoracic organs.
The study design was a retrospective cohort study comparing two groups of brain-dead donors: those who required ECMO support and those who did not. The ECMO group consisted of 25 donors who were placed on veno-arterial or veno-venous ECMO at any point during their critical care management before organ procurement. These patients typically suffered cardiac arrest and were resuscitated with ECPR or developed refractory cardiopulmonary failure requiring ECMO to maintain organ perfusion. The control group comprised 185 donors who did not require ECMO, receiving standard care such as mechanical ventilation and vasopressor support. In South Korea, donation after circulatory death is not legally permitted, so all donations in this study followed the DBD pathway.
Baseline demographics and causes of brain death were broadly comparable between the two groups, although the ECMO donors more frequently had antecedent cardiac arrest, occurring in 76.0% of the ECMO group versus 53.5% in the control group. This difference reflects a population that would likely not have survived to brain death determination without extracorporeal support. Among the ECMO donors, veno-arterial ECMO was used in 76.0% of cases, while veno-venous ECMO was used in 24.0%. ECPR at initiation was documented in 68.0% of cases, and cannulation most frequently occurred in the intensive care unit or the emergency department. ECMO-related complications were uncommon, with cannulation-site bleeding observed in 16.0% of cases and no recorded thrombotic or limb ischemic events.
For organ-recovery analyses, one ECMO donor was excluded due to inter-hospital transfer, leaving 24 ECMO donors for comparison. Thoracic organ recovery was markedly lower in the ECMO group, with heart recovery rates of 4.2% compared to 47.6% in the control group, and lung recovery rates of 4.2% compared to 47.0%. Both differences were statistically significant with P values less than 0.001. This disparity was attributable primarily to underlying cardiopulmonary pathology, such as post-cardiopulmonary resuscitation myocardial dysfunction or acute cardiac pathology, which precluded the use of these organs. In contrast, abdominal organ recovery was preserved, with comparable rates for liver, right kidney, and left kidney between the two groups.
Specifically, liver recovery rates were 75.0% in the ECMO group versus 84.3% in the control group, a difference that was not statistically significant. Kidney recovery rates were also similar, with right kidney recovery at 87.5% versus 89.7% and left kidney recovery at 87.5% versus 91.4%. The median number of recovered organs per donor was lower in ECMO donors compared with controls, at 3.0 versus 4.0 organs. Despite representing a high-acuity population with a median Sequential Organ Failure Assessment score of 16.0 and peak lactate levels of 9.9 mmol/L, the abdominal organ-recovery rates among ECMO donors were comparable to those of standard donors, indicating that ECMO support effectively maintained organ viability in these critical patients.
Recipient survival was evaluated using Kaplan–Meier analysis with log-rank testing, stratified by donor ECMO exposure and organ type. For kidney recipients, there were no significant between-group differences in survival, with P values of 0.15 for right kidney and 0.12 for left kidney. Liver recipient survival differed significantly between groups, with the ECMO group showing a higher survival probability at late follow-up, a finding with a log-rank P value of 0.02. However, the authors cautioned that this finding is hypothesis-generating and should be interpreted with caution due to the small number of events and the potential for selection bias, as liver grafts were accepted more selectively from ECMO donors.
The study highlights the importance of ECMO in expanding the donor pool in settings where donation after circulatory death is unavailable. ECMO functions not only as life-sustaining therapy but also as a bridge that converts potential non-donors into viable DBD donors. This is particularly relevant for patients with secondary hypoxic brain injury due to circulatory failure, who have traditionally been underutilized for organ donation. The findings suggest that with appropriate donor management, ECMO may be associated with maintained systemic perfusion and organ function sufficient to support transplantation despite severe initial circulatory compromise.
However, the increasing use of ECPR and ECMO in cardiac arrest patients raises ethical and social considerations. ECPR is primarily initiated with the intent of saving the patient’s life, not as a bridge to organ donation. When patients subsequently progress to brain death, this shift in purpose can create a perceived ethical collision between therapeutic and donor-focused objectives. Families often experience emotional distress and may not be prepared to engage in discussions about organ donation immediately after ECPR initiation. These sensitive conversations may require more time and careful communication than current clinical pathways allow, highlighting the need for transparent policies and ethical frameworks.
The study has several limitations, including a relatively small sample size and the retrospective design, which introduces inherent selection bias. The comparison between ECMO-supported donors and non-ECMO controls was substantially imbalanced, as ECMO-supported brain death is a rare clinical event. Additionally, standardized protocols for ECMO donor management are lacking, and long-term outcomes were not systematically captured. Post-transplant outcomes were assessed as recipient survival rather than true graft survival, with graft-loss events such as return to renal replacement therapy not systematically captured. These factors suggest that the findings are exploratory and warrant confirmation in larger prospective studies.
The late divergence of liver recipient survival curves should be interpreted cautiously, as only a single graft-loss event occurred among ECMO liver recipients, making the Kaplan–Meier estimate statistically fragile. Median follow-up differed between groups, reflecting an era effect from the earlier concentration of ECMO donors. Liver grafts were accepted more selectively from ECMO donors, introducing a potential survival bias. These factors suggest the late dissociation is hypothesis-generating and warrants confirmation in larger cohorts. Future efforts should focus on optimizing thoracic organ utilization among ECMO-supported donors, as most hearts and lungs were excluded due to primary cardiopulmonary pathology.
Implementing more comprehensive cardiac and pulmonary evaluation protocols, including advanced echocardiography and biomarker assessment, may help identify additional thoracic allografts suitable for transplantation. Concurrently, continued refinement of ECMO management protocols for potential donors, along with multidisciplinary coordination between ECMO, intensive care, and transplant teams, could further improve organ quality and outcomes. In South Korea, where DBD remains the only legally authorized pathway for deceased donation, the importance of maximizing organ recovery from each potential donor is especially critical. The present study highlights that ECMO-supported DBD donors can contribute meaningfully to expanding the donor pool, with post-transplant outcomes comparable to conventional DBD.
As countries debate the introduction of donation after circulatory death, incorporating ECMO-supported DBD strategies should be considered in parallel as part of a broader, complementary framework for donor pool expansion. Rather than competing, these two strategies can coexist within a comprehensive national donation framework, each addressing different clinical pathways and donor populations. In systems where donation after circulatory death is not legally permitted, ECMO-supported DBD may provide a practical and ethically acceptable alternative for donor pool expansion. This study provides valuable insights into the feasibility and outcomes of organ procurement from ECMO-supported brain-dead donors, contributing to the growing body of evidence on this important clinical and policy issue.
Subject of Research: Organ utilization and post-transplant outcomes in ECMO-supported brain-dead donors
Article Title: Utilization and outcomes of organs from ECMO-supported brain-dead donors: two-center experience
Article References: Chung, J., Ko, R.-E., Cha, S., Oh, S., Lim, S. K., Yang, J. H., Sung, K., Ju, M. H., & Cho, Y. H. (2026). Utilization and outcomes of organs from ECMO-supported brain-dead donors: two-center experience. Journal of Intensive Care, 14(1), Article 98. https://doi.org/10.1186/s40560-026-00933-z
Image Credits: AI Generated
DOI: 10.1186/s40560-026-00933-z
Keywords: ECMO, brain death, organ donation, retrospective cohort, South Korea, abdominal organs, thoracic organs, recipient survival, donor pool expansion, cardiopulmonary resuscitation, liver transplantation, kidney transplantation, organ procurement, clinical outcomes, intensive care, medical ethics, donation after brain death, extracorporeal membrane oxygenation, organ viability, post-transplant survival
Cite Scienmag News
Cassandra Pierce. (November 21, 2026). ECMO-Supported Brain-Dead Donors Yield Comparable Abdominal Organs. Scienmag. https://scienmag.com/ecmo-supported-brain-dead-donors-yield-comparable-abdominal-organs/
Cassandra Pierce. "ECMO-Supported Brain-Dead Donors Yield Comparable Abdominal Organs." Scienmag, 21 November 2026, https://scienmag.com/ecmo-supported-brain-dead-donors-yield-comparable-abdominal-organs/. Accessed 21 November 2026.
Cassandra Pierce. "ECMO-Supported Brain-Dead Donors Yield Comparable Abdominal Organs." Scienmag. November 21, 2026. https://scienmag.com/ecmo-supported-brain-dead-donors-yield-comparable-abdominal-organs/








